This or That at SDPA Summer Dermatology Conference: Sunscreens
What's the preferred sunscreen and why? Renata Block, MMS, PA-C, talks to the attendees of the 2024 SDPA Annual Summer Dermatology Conference.
A Conversation With Amber Blair, MMS, PA-C, at the SDPA Conference
The SDPA President Elect shared insights, hopes for the field, and the importance of leadership.
SDPA Literature Review Session Shares Clinical Pearls
This special literature review yields a deeper understanding of issues like treating acne, nutraceuticals, and more.
A Positive Outlook With Laura Bush, DMSc, PA-C, DFAAPA
Laura Bush, DMSc, PA-C, DFAAPA, talks to Renata Block, MMS, PA-C, about her SDPA presidency, the future, and the importance of a positive outlook.
Quality of Life Improved in GPP in Effisayil 2 Trial
Poster presented at the SDPA conference reported Effisayil 2 data indicating spesolimab improved Dermatology Life Quality Index scores in patients with generalized pustular psoriasis.
Journey of Philanthropy and Leadership
Renata Block, MMS, PA-C, and Faseeha Raza, PA-C, discuss the DPAF, philanthropy, leadership, and the importance of patient care.
Getting JAK’d With Amy Spizuoco, DO, FAOCD
The JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.
An Evolving Field: A Conversation With Renata Block, MMS, PA-C
What are some of the opportunities and challenges facing PAs today? Renata Block, MMS, PA-C, shares insights and reflections on the field.
Brodalumab Performs in Phase 4 Studies of Moderate to Severe Psoriasis
The results indicated improvement in PASI and sPGA scores as well as improvement in quality of life indicators in adults with moderate to severe psoriasis.
SDPA Poster Reports Positive Phase 3 Results of Dupilumab for PN
Researchers found dupilumab improved itch and skin lesions regardless of atopic disease status in patients with PN.
Hands-on Workshop Empowers Clinicians in Cosmetic Dermatology
Robin Siperstein, MD, FAAD, shares practical tips in cosmetic dermatology at the 2024 SDPA Annual Summer Dermatology Meeting.
Finding “Positive Exposure”: Organization Promotes Diversity and Reframes Beauty
Session at the 2024 SDPA Annual Summer Dermatology Conference helps clinicians reframe beauty and empower patients.
Previewing the 2024 SDPA Annual Summer Dermatology Conference
From posters to sessions, this year's SDPA Summer Dermatology Conference was designed to provide clinicians with insights from leading experts.
POLL: What Skills Are You Most Hoping to Learn at the 2024 SDPA Summer Conference?
With so many sessions and posters, there is a plethora of topics offered at this year's SDPA Summer Conference.
2024 Fall Clinical Dermatology Conference for PAs and NPs Coverage Recap
Catch up on a weekend full of clinical pearls from the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.
Dermatology Conferences and Meetings Calendar 2024: June
Dermatology Times asked our readers to share what conferences they are looking forward to in the second quarter of 2024.
Day 3 Recap: 2024 Fall Clinical Dermatology Conference for PAs and NPs
Catch up on coverage from the last day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.
Understanding the Mechanism of Action in JAK Inhibitors
Jason Hawkes, MD, MS, detailed each of the kinases' association with different cytokine receptors and biological functions.
Combining Systemic Therapies in Psoriasis and Atopic Dermatitis
James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety.
Biologics and Pregnancy: A Q&A With Ben Lockshin, MD
Lockshin shared his approach to continuing biologic therapies into pregnancy with informed timing adjustments.
